课题基金 / 基金详情

Respiratory Control Stability in Obstructive Sleep Apnea

Respiratory Control Stability in Obstructive Sleep Apnea
阻塞性睡眠呼吸暂停的呼吸控制稳定性
批准号:
6731069
负责人:
DAVID ANDREW WELLMAN
金额:
$5.86万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-01 至 2005-04-30

项目摘要

项目成果

DAVID ANDREW WELLMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Obstructive sleep apnea (OSA) is a common disorder characterized by recurrent collapse of the pharyngeal airway during sleep. There is evidence to suggest that respiratory control instability (RCI) is an important contributor to OSA pathogenesis. A novel technique for quantifying RCI has recently been introduced and involves the measurement of respiratory system loop gain (LG). LG is an engineering term that describes the instability in a mechanical or physiologic system governed by feedback control loops. Mathematically, it is defined as the ratio of a corrective response (e.g., hyperpnea) to a disturbance (e.g., apnea). If the corrective action is greater in magnitude than the disturbance (LG > 1), the system is said to be unstable and has the potential for sustained, periodic fluctuations (e.g., in ventilation and blood gases) when disturbed. The purpose of this proposal is to use this new technique to better define the role of RCI and OSA pathogenesis. Specifically, we propose to: 1. Modify the current technique by measuring LG under mildly hypoxic conditions, which we believe will allow us to quantify RCI in individuals with stable (LG close to zero) respiratory control. 2. Measure LG and upper airway collapsibility (pharyngeal closing pressure, Pcrit) in patients with a spectrum of apnea severity to determine if: a. Individuals with relatively upper airway collapsibility (Pcrit) require a high LG (LG close to 1) to develop OSA. b. High LG, independent of upper airway collapsibility, is associated with more severe (more frequently apneas) OSA. c. Lower LG will reduce OSA severity in patients with high LG.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Predicting response to non-PAP therapies in OSA using PSG-derived endotypes
  • 批准号:
    10440108
  • 项目类别:
  • 资助金额:
    $81.62万
  • 财政年份:
    2022
  • 负责人:
    DAVID ANDREW WELLMAN
  • 依托单位:
Predicting response to non-PAP therapies in OSA using PSG-derived endotypes
  • 批准号:
    10705062
  • 项目类别:
  • 资助金额:
    $79.65万
  • 财政年份:
    2022
  • 负责人:
    DAVID ANDREW WELLMAN
  • 依托单位:
Project 5
Project 5
海外基金